EVONILE MTF Data: Margin Funding in Evonile Pharma Limited
Evonile Pharma Limited has ₹11.57 crore financed under MTF, 0.23% of its shares. The book is down 13.3% in a month and up 656.6% in a year. At the last close the financed shares were worth 7.8% less than the amount financed.
EVONILE MTF book and price
Daily for the last two years, weekly before that. The book is the exchange-reported amount financed.
Holders' cost vs the market
Amount financed ÷ shares financed approximates the average price margin holders paid. When the close is below that line, margin holders are, on average, sitting on a loss.
Shares financed
Share counts move only when margin holders buy or sell (and on splits and bonuses), not with the price.
Net new margin buying, by month
Each day's change in shares financed valued at that day's close, summed by month: buying and selling on margin without the effect of price. Split and bonus credits are removed.
Leverage and days to cover
Share of the company's shares on margin (month end) and how many days of average NSE volume they equal.
Records & stats
| Latest book | ₹11.57 Cr |
| Flow: 1 / 5 / 20 sessions | +₹14.6 L · −₹8.6 L · −₹1.54 Cr |
| Change: 1 week / 1 month / 3 months / 1 year | -0.7% · -13.3% · +330.3% · +656.6% |
| All-time high | ₹13.46 Cr 7 Oct 2026 |
| Low since first funded | ₹0 10 Aug 2017 |
| Biggest one-day build | +₹1.90 Cr 13 Jul 2026 |
| Biggest one-day unwind | −₹91.7 L 9 Jul 2021 |
| Below its peak | 14.0% |
| Average book while funded | ₹1.28 Cr |
| Most shares financed | 66,566 20 Jul 2023 |
| Funded since | 9 Aug 2017 (1,313 sessions with a book) |
Month by month
| Month | Book | Net buying | % of shares | Days to cover |
|---|---|---|---|---|
| 2026-11 | ₹11.57 Cr | −₹11.1 L | 0.23% | 0.9 |
| 2026-10 | ₹11.96 Cr | +₹58.2 L | 0.23% | 1.2 |
| 2026-09 | ₹11.63 Cr | +₹7.24 Cr | 0.22% | 0.2 |
| 2026-08 | ₹3.16 Cr | −₹30.1 L | 0.08% | 1.3 |
| 2026-07 | ₹3.48 Cr | +₹2.15 Cr | 0.08% | 0.4 |
| 2026-06 | ₹1.13 Cr | −₹25.6 L | 0.03% | 0.3 |
| 2026-05 | ₹1.46 Cr | +₹1.23 Cr | 0.04% | 0.2 |
| 2026-04 | ₹28.7 L | +₹4.2 L | 0.00% | 0.0 |
| 2026-03 | ₹33.4 L | +₹0 | 0.00% | — |
| 2026-02 | ₹99.3 L | +₹0 | 0.00% | — |
| 2026-01 | ₹72.4 L | +₹0 | 0.00% | — |
| 2025-12 | ₹1.29 Cr | +₹0 | 0.00% | — |
Questions
How much margin trading funding does EVONILE have?
On 9 Nov 2026, ₹11.57 Cr of Evonile Pharma Limited shares were held under the margin trading facility, 56,547 shares on NSE.
What share of EVONILE is bought on margin?
About 0.23% of all its shares.
Are margin holders of EVONILE in profit?
At the last close the financed shares were worth 7.8% less than the amount financed. The amount financed reflects purchase values, so this is an estimate of margin holders' average unrealised gain or loss.
Where does this data come from?
Exchange data: the daily margin trading disclosures, with prices and share counts from the exchange. See the methodology.
Figures for the 9 Nov 2026 session · last updated 2026-11-12 07:47 IST · Source: Exchange data · 9/10 data checks passed.
How to read this page. Everything here describes what the exchanges have already disclosed about margin-funded (MTF) positions. It is not a forecast, a recommendation, or a signal to buy or sell. Words such as "crowded", "fragile" or "underwater" name a pattern in the numbers, nothing more. Margin funding carries the risk of losses larger than the money you put in.
Flash Finance is not a SEBI-registered investment adviser and is not affiliated with NSE, BSE or SEBI. Exchange data may be revised by the exchange. Verify anything you intend to act on against the exchange's own records.
